Marshall Wace North America’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-113,325
Closed -$5.96M 1390
2020
Q2
$5.96M Sell
113,325
-9,574
-8% -$454K 0.04% 346
2020
Q1
$4.33M Buy
122,899
+121,750
+10,596% +$7.11M 0.03% 346
2019
Q4
$100K Sell
1,149
-19,025
-94% -$1.66M ﹤0.01% 1063
2019
Q3
$1.71M Sell
20,174
-37,208
-65% -$3.31M 0.01% 577
2019
Q2
$6.04M Buy
57,382
+56,971
+13,862% +$5.72M 0.04% 322
2019
Q1
$44K Sell
411
-50,818
-99% -$5.1M ﹤0.01% 1286
2018
Q4
$4.29M Buy
+51,229
New +$4.64M 0.04% 270
2018
Q3
Sell
-245,316
Closed -$19.8M 1219
2018
Q2
$19.8M Sell
245,316
-129,311
-35% -$10.3M 0.11% 205
2018
Q1
$27.6M Buy
374,627
+44,994
+14% +$3.37M 0.14% 168
2017
Q4
$23.2M Sell
329,633
-91,962
-22% -$6.63M 0.13% 193
2017
Q3
$26.1M Buy
421,595
+157,621
+60% +$9.34M 0.17% 169
2017
Q2
$15M Buy
263,974
+258,180
+4,456% +$15.2M 0.11% 238
2017
Q1
$353K Buy
+5,794
New +$328K ﹤0.01% 853

Other funds holding NGVT

Marshall Wace North America's NGVT Position: Q3 2020 in Review

Marshall Wace North America sold out of Ingevity (NGVT) in Q3 2020, closing a stake of 113,325 shares — an estimated $5.96M sold.

Marshall Wace North America first reported a position in NGVT in Q1 2017 and held it in 13 quarters. The position peaked at $27.6M in Q1 2018. 283 funds tracked by Wall St. Rank hold NGVT as of Q3 2020.

  • Marshall Wace North America reported no remaining Ingevity position as of Q3 2020 after selling out during the quarter.
  • Marshall Wace North America sold 113,325 Ingevity shares in Q3 2020, an estimated $5.96M.
  • Marshall Wace North America first reported a position in Ingevity in Q1 2017 and held it in 13 quarters.
  • Marshall Wace North America's Ingevity position peaked at $27.6M in Q1 2018.
  • 283 funds tracked by Wall St. Rank held Ingevity as of Q3 2020.

Based on Marshall Wace North America's 13F filing for Q3 2020, filed 16 Nov 2020.